E.U. Revises Law on Data Sharing

The newly amended legislation frees up health data, reversing an earlier provision that made it difficult for broad use of such information in research, registries, and biobanks.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

European Parliament gets scientist friendly with changes to a sweeping data sharing lawWIKIMEDIA, JLOGANEuropean officials last week (December 15) announced that they had rewritten draft legislation, changing a provision limiting researchers’ access to personal health data. The provision, added by the European Parliament last March, would have made it difficult for researchers to use personal health data, forcing them to obtain new permissions from study subjects if and when the focus of research changed, and prohibiting study subjects from granting broad consent even if they wanted to. “We are delighted with the outcome,” Beth Thompson, a policy adviser at the Wellcome Trust in London who helped organize a campaign to persuade officials to revise the draft legislation, told ScienceInsider. The “compromise solution works for both the research community and the people.”

The newest incarnation of the three-year-old legislation grants researchers access to data for which patients have given broad consent—with assurances regarding privacy protection and strict ethical approval—and allows scientists to use such data in perpetuity as long as consent is not withdrawn. The change came after a coalition of European research organizations banded together to influence the European Commission, the European Parliament, and the European Council, which negotiated to reach the legislation’s current form. “Researchers will now be able to continue exploring new research opportunities with data under laws that are fit for purpose,” Thompson said in a statement. According to ScienceInsider, the law is expected to be approved early next year.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies